Literature DB >> 16870787

Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Emma Huitric1, Jim Werngren, Pontus Juréen, Sven Hoffner.   

Abstract

The distribution and resistance levels of 189 in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants of Beijing and other genotypes were determined. Apart from a higher amount of codon 522 point mutations and large deletions, a spread of mutations similar to that reported for clinical isolates was seen. Most mutations were correlated with high-level resistance; a lower level, or a MIC of <16 mg/liter, was associated with codon 522 mutations. Multiple mutations were detected in two Beijing mutants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870787      PMCID: PMC1538691          DOI: 10.1128/AAC.00303-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia.

Authors:  O Narvskaya; T Otten; E Limeschenko; N Sapozhnikova; O Graschenkova; L Steklova; A Nikonova; M L Filipenko; I Mokrousov; B Vyshnevskiy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-08-15       Impact factor: 3.267

3.  Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate.

Authors:  Jim Werngren; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.

Authors:  G P Morlock; B B Plikaytis; J T Crawford
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.

Authors:  W Sougakoff; M Rodrigue; C Truffot-Pernot; M Renard; N Durin; M Szpytma; R Vachon; A Troesch; V Jarlier
Journal:  Clin Microbiol Infect       Date:  2004-04       Impact factor: 8.067

Review 8.  Drug resistance in Mycobacterium tuberculosis.

Authors:  S T Cole; A Telenti
Journal:  Eur Respir J Suppl       Date:  1995-09

9.  Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.

Authors:  Deneke H Mariam; Yohannes Mengistu; Sven E Hoffner; Dan I Andersson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review.

Authors:  Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more
  18 in total

1.  Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.

Authors:  Gail E Louw; Robin M Warren; Nicolaas C Gey van Pittius; Rosalba Leon; Adelina Jimenez; Rogelio Hernandez-Pando; Christopher R E McEvoy; Melanie Grobbelaar; Megan Murray; Paul D van Helden; Thomas C Victor
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence.

Authors:  O J Strauss; R M Warren; A Jordaan; E M Streicher; M Hanekom; A A Falmer; H Albert; A Trollip; E Hoosain; P D van Helden; T C Victor
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

Review 3.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.

Authors:  Sönke Andres; Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

5.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.

Authors:  Noboru Nakata; Masanori Kai; Masahiko Makino
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 7.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

8.  Characterization of mutations in the rpoB gene conferring rifampicin resistance in Mycobacterium tuberculosis complex isolated from lymph nodes of slaughtered cattle from South Africa.

Authors:  Nolwazi L Bhembe; Ezekiel Green
Journal:  Braz J Microbiol       Date:  2020-08-05       Impact factor: 2.476

9.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

10.  Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin.

Authors:  Anna Zaczek; Anna Brzostek; Ewa Augustynowicz-Kopec; Zofia Zwolska; Jaroslaw Dziadek
Journal:  BMC Microbiol       Date:  2009-01-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.